Literature DB >> 27130534

Foodomics as part of the host-microbiota-exposome interplay.

Lorenza Putignani1, Bruno Dallapiccola2.   

Abstract

UNLABELLED: The functional complexity of human gut microbiota and its relationship with host physiology and environmental modulating factors, offers the opportunity to investigate (i) the host and microbiota role in organism-environment relationship; (ii) the individual functional diversity and response to environmental stimuli (exposome); (iii) the host genome and microbiota metagenomes' modifications by diet-mediated epigenomic controls (nutriepigenomics); and (iv) the genotype-phenotype "trajectories" under physiological and disease constraints. Systems biology-based approaches aim at integrating biological data at cellular, tissue and organ organization levels, using computational modeling to interpret diseases' physiopathological mechanisms (i.e., onset and progression). Proteomics improves the existing gene models by profiling molecular phenotypes at protein abundance level, by analyzing post-translational modifications and protein-protein interactions and providing specific pathway information, hence contributing to functional molecular networks. Transcriptomics and metabolomics may determine host ad microbiota changes induced by food ingredients at molecular level, complementing functional genomics and proteomics data. Since foodomics is an -omic wide methodology may feed back all integrative data to foster the omics-based systems medicine field. Hence, coupled to ecological genomics of gut microbial communities, foodomics may highlight health benefits from nutrients, dissecting diet-induced gut microbiota eubiosis mechanisms and significantly contributing to understand and prevent complex disease phenotypes. BIOLOGICAL SIGNIFICANCE: Besides transcriptomics and proteomics there is a growing interest in applying metabolic profiling to food science for the development of functional foods. Indeed, one of the biggest challenges of modern nutrition is to propose a healthy diet to populations worldwide, intrinsically respecting the high inter-individual variability, driven by complex host/nutrients/microbiota/environment interactions. Therefore, metabolic profiling can assist at various levels for the development of functional foods, starting from screening for food composition to identification of new biomarkers to trace food intake. This current approach can support diet intervention strategies, epidemiological studies, and controlling of metabolic disorders worldwide spreading, hence ensuring healthy aging. With high-throughput molecular technologies driving foodomics, studying bidirectional interactions of host-microbial co-metabolism, innate immune development, dysfunctional nutrient absorption and processing, complex signaling pathways involved in nutritional metabolism, is now likely. In all cases, as microbiome pipeline efforts continue, it is possible that enhanced standardized protocols can be developed, which may lead to new testable biological and clinical hypotheses. This Review provides a comprehensive update on the current state-of-the-art of the integrated -omics route in food, microbiota and host co-metabolism studies, which may revolutionize the design of new dietary intervention strategies.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Data integration; Foodomics; Panomics; Phenomics; Systems biology; Systems medicine

Mesh:

Year:  2016        PMID: 27130534     DOI: 10.1016/j.jprot.2016.04.033

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  14 in total

1.  Gut microbiome beats two to zero host genome.

Authors:  Giovanni Cammarota; Lorenza Putignani; Antonio Gasbarrini
Journal:  Hepatobiliary Surg Nutr       Date:  2019-08       Impact factor: 7.293

2.  Gut Microbiota Ecology and Inferred Functions in Children With ASD Compared to Neurotypical Subjects.

Authors:  Pamela Vernocchi; Maria Vittoria Ristori; Silvia Guerrera; Valerio Guarrasi; Federica Conte; Alessandra Russo; Elisabetta Lupi; Sami Albitar-Nehme; Simone Gardini; Paola Paci; Gianluca Ianiro; Stefano Vicari; Antonio Gasbarrini; Lorenza Putignani
Journal:  Front Microbiol       Date:  2022-06-09       Impact factor: 6.064

Review 3.  Association Between Gut Microbiota and Bone Health: Potential Mechanisms and Prospective.

Authors:  Yuan-Cheng Chen; Jonathan Greenbaum; Hui Shen; Hong-Wen Deng
Journal:  J Clin Endocrinol Metab       Date:  2017-10-01       Impact factor: 5.958

4.  Novel Biomarkers of Habitual Alcohol Intake and Associations With Risk of Pancreatic and Liver Cancers and Liver Disease Mortality.

Authors:  Erikka Loftfield; Magdalena Stepien; Vivian Viallon; Laura Trijsburg; Joseph A Rothwell; Nivonirina Robinot; Carine Biessy; Ingvar A Bergdahl; Stina Bodén; Matthias B Schulze; Manuela Bergman; Elisabete Weiderpass; Julie A Schmidt; Raul Zamora-Ros; Therese H Nøst; Torkjel M Sandanger; Emily Sonestedt; Bodil Ohlsson; Verena Katzke; Rudolf Kaaks; Fulvio Ricceri; Anne Tjønneland; Christina C Dahm; Maria-Jose Sánchez; Antonia Trichopoulou; Rosario Tumino; María-Dolores Chirlaque; Giovanna Masala; Eva Ardanaz; Roel Vermeulen; Paul Brennan; Demetrius Albanes; Stephanie J Weinstein; Augustin Scalbert; Neal D Freedman; Marc J Gunter; Mazda Jenab; Rashmi Sinha; Pekka Keski-Rahkonen; Pietro Ferrari
Journal:  J Natl Cancer Inst       Date:  2021-11-02       Impact factor: 13.506

Review 5.  Why Are Omics Technologies Important to Understanding the Role of Nutrition in Inflammatory Bowel Diseases?

Authors:  Lynnette R Ferguson; Matthew P G Barnett
Journal:  Int J Mol Sci       Date:  2016-10-21       Impact factor: 5.923

6.  Embracing Complexity beyond Systems Medicine: A New Approach to Chronic Immune Disorders.

Authors:  Anje A Te Velde; Tjitske Bezema; Antoine H C van Kampen; Aletta D Kraneveld; Bert A 't Hart; Henriët van Middendorp; Erik C Hack; Joris M van Montfrans; Clara Belzer; Lilian Jans-Beken; Raymond H Pieters; Karen Knipping; Machteld Huber; Annemieke M H Boots; Johan Garssen; Tim R Radstake; Andrea W M Evers; Berent J Prakken; Irma Joosten
Journal:  Front Immunol       Date:  2016-12-12       Impact factor: 7.561

7.  A Metagenomic and in Silico Functional Prediction of Gut Microbiota Profiles May Concur in Discovering New Cystic Fibrosis Patient-Targeted Probiotics.

Authors:  Pamela Vernocchi; Federica Del Chierico; Andrea Quagliariello; Danilo Ercolini; Vincenzina Lucidi; Lorenza Putignani
Journal:  Nutrients       Date:  2017-12-09       Impact factor: 5.717

8.  A Perspective and Framework for Developing Sample Type Specific Databases for LC/MS-Based Clinical Metabolomics.

Authors:  Nichole A Reisdorph; Scott Walmsley; Rick Reisdorph
Journal:  Metabolites       Date:  2019-12-21

Review 9.  Rebuilding the Gut Microbiota Ecosystem.

Authors:  Antonella Gagliardi; Valentina Totino; Fatima Cacciotti; Valerio Iebba; Bruna Neroni; Giulia Bonfiglio; Maria Trancassini; Claudio Passariello; Fabrizio Pantanella; Serena Schippa
Journal:  Int J Environ Res Public Health       Date:  2018-08-07       Impact factor: 3.390

10.  Enlarging Knowledge on Lager Beer Volatile Metabolites Using Multidimensional Gas Chromatography.

Authors:  Cátia Martins; Tiago Brandão; Adelaide Almeida; Sílvia M Rocha
Journal:  Foods       Date:  2020-09-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.